DE69932183D1 - ANWENDUNG VON ZIELGERICHTETEM RADIUM 223 FüR PALLIATIVE UND THERAPEUTISCHE BEHANDLUNG VON KNOCHENKREBS - Google Patents
ANWENDUNG VON ZIELGERICHTETEM RADIUM 223 FüR PALLIATIVE UND THERAPEUTISCHE BEHANDLUNG VON KNOCHENKREBSInfo
- Publication number
- DE69932183D1 DE69932183D1 DE69932183T DE69932183T DE69932183D1 DE 69932183 D1 DE69932183 D1 DE 69932183D1 DE 69932183 T DE69932183 T DE 69932183T DE 69932183 T DE69932183 T DE 69932183T DE 69932183 D1 DE69932183 D1 DE 69932183D1
- Authority
- DE
- Germany
- Prior art keywords
- radium
- palliative
- targeted
- application
- therapeutic treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000018084 Bone neoplasm Diseases 0.000 title abstract 2
- HCWPIIXVSYCSAN-OIOBTWANSA-N radium-223 Chemical compound [223Ra] HCWPIIXVSYCSAN-OIOBTWANSA-N 0.000 title abstract 2
- 229960005562 radium-223 Drugs 0.000 title abstract 2
- 206010005949 Bone cancer Diseases 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 210000000988 bone and bone Anatomy 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000004872 soft tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Biological Depolymerization Polymers (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Materials For Medical Uses (AREA)
- Radiation-Therapy Devices (AREA)
- Compounds Of Unknown Constitution (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO990001 | 1999-01-04 | ||
NO990001A NO310544B1 (no) | 1999-01-04 | 1999-01-04 | Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben |
PCT/NO1999/000392 WO2000040275A2 (en) | 1999-01-04 | 1999-12-17 | The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69932183D1 true DE69932183D1 (de) | 2006-08-10 |
DE69932183T2 DE69932183T2 (de) | 2007-05-16 |
Family
ID=19902803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69932183T Expired - Lifetime DE69932183T2 (de) | 1999-01-04 | 1999-12-17 | ANWENDUNG VON ZIELGERICHTETEM RADIUM 223 FüR PALLIATIVE UND THERAPEUTISCHE BEHANDLUNG VON KNOCHENKREBS |
Country Status (25)
Country | Link |
---|---|
US (2) | US6635234B1 (de) |
EP (1) | EP1140212B1 (de) |
JP (2) | JP4649044B2 (de) |
KR (1) | KR100671387B1 (de) |
CN (2) | CN1767078B (de) |
AT (1) | ATE331534T1 (de) |
AU (1) | AU774991B2 (de) |
BE (1) | BE2014C028I2 (de) |
BR (1) | BR9916768A (de) |
CA (1) | CA2358498C (de) |
CY (2) | CY1105634T1 (de) |
DE (1) | DE69932183T2 (de) |
DK (1) | DK1140212T3 (de) |
EA (1) | EA003496B1 (de) |
ES (1) | ES2268888T3 (de) |
HK (1) | HK1090750A1 (de) |
IL (1) | IL144135A0 (de) |
LU (1) | LU92425I2 (de) |
MX (1) | MXPA01006823A (de) |
NO (2) | NO310544B1 (de) |
NZ (3) | NZ513135A (de) |
PT (1) | PT1140212E (de) |
TR (3) | TR200201440T2 (de) |
WO (1) | WO2000040275A2 (de) |
ZA (1) | ZA200105431B (de) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO310544B1 (no) * | 1999-01-04 | 2001-07-23 | Algeta As | Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben |
NO314537B1 (no) * | 1999-12-06 | 2003-04-07 | Anticancer Therapeutic Inv Sa | Reseptorbindende konjugater |
NO313180B1 (no) | 2000-07-04 | 2002-08-26 | Anticancer Therapeutic Inv Sa | Bensökende alfapartikkel emitterende radiofarmasöytika |
AUPQ923100A0 (en) * | 2000-08-07 | 2000-08-31 | Peplin Research Pty Ltd | Treatment of prostate cancer |
CA2472578A1 (en) * | 2002-01-24 | 2003-07-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Anti-cancer combination and use thereof |
GB0213261D0 (en) * | 2002-06-10 | 2002-07-17 | Anticancer Therapeutic Inv Sa | Method |
GB0308731D0 (en) * | 2003-04-15 | 2003-05-21 | Anticancer Therapeutic Inv Sa | Method of radiotherapy |
DE602004009184T2 (de) | 2003-04-30 | 2008-07-03 | Ramot At Tel Aviv University Ltd. | Verfahren und vorrichtung für die strahlentherapie |
US8142758B2 (en) * | 2004-02-20 | 2012-03-27 | Algeta As | Alpha-emitting hydroxyapatite particles |
DE102004022200B4 (de) * | 2004-05-05 | 2006-07-20 | Actinium Pharmaceuticals, Inc. | Radium-Target sowie Verfahren zu seiner Herstellung |
US7914766B1 (en) * | 2004-06-03 | 2011-03-29 | Ut-Battelle Llc | Inorganic resins for clinical use of 213Bi generators |
GB0423565D0 (en) * | 2004-10-22 | 2004-11-24 | Algeta As | Formulation |
LT1909855T (lt) * | 2005-07-26 | 2018-05-25 | Aplha Tau Medical Ltd. | Radioaktyvaus paviršiaus šaltinis, ir būdas jam sukurti |
US8709380B1 (en) * | 2006-02-07 | 2014-04-29 | Sirius Medicine, Llc | Targeting agents for enhancing radiation therapy |
DE102006008023B4 (de) * | 2006-02-21 | 2008-05-29 | Actinium Pharmaceuticals, Inc. | Verfahren zum Reinigen von 225Ac aus bestrahlten 226Ra-Targets |
EP2796575B8 (de) * | 2006-09-08 | 2020-04-01 | Actinium Pharmaceuticals, Inc. | Verfahren zur Reinigung von Radium aus verschiedenen Quellen |
EP2116539A1 (de) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-Aryl-3-Amino-alkoxy-pyrazole als Sigma-Liganden zur Verbesserung der analgetischen Wirkung von Opioiden und zur Schwächung der Abhängigkeit davon |
EP2353591A1 (de) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma-Liganden zur Verstärkung der analgesischen Wirkung von Opioden und Opiaten bei postoperativem Schmerz und zur Schwächung der Abhängigkeit davon |
EP2353598A1 (de) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma-Liganden zur Anwendung in der Vorbeugung und/oder Behandlung von postoperativem Schmerz |
GB201002508D0 (en) | 2010-02-12 | 2010-03-31 | Algeta As | Product |
GB201007354D0 (en) * | 2010-04-30 | 2010-06-16 | Algeta Asa | Method |
GB201007353D0 (en) * | 2010-04-30 | 2010-06-16 | Algeta Asa | Method |
EP2388005A1 (de) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma-Liganden zur Vorbeugung und/oder Behandlung von Erbrechen infolge von Chemotherapie oder Strahlentherapie |
EP2415471A1 (de) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Verwendung von Sigmaliganden bei opioidinduzierter Hyperalgesie |
EP2524694A1 (de) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Verwendung von Sigmaliganden bei Schmerz im Zusammenhang mit Typ-2-Diabetes |
WO2014095833A1 (en) | 2012-12-19 | 2014-06-26 | Bayer Pharma Aktiengesellschaft | Combination comprising radium-223 for the treatment of cancer |
GB201314718D0 (en) * | 2013-08-16 | 2013-10-02 | Algeta As | Quantification method |
CA2932221C (en) | 2013-12-03 | 2022-02-22 | Bayer Pharma Aktiengesellschaft | Combination of pi3k-inhibitors |
EP3077003A1 (de) | 2013-12-03 | 2016-10-12 | Bayer Pharma Aktiengesellschaft | Kombination von pi3k-inhibitoren |
KR20160097366A (ko) | 2013-12-17 | 2016-08-17 | 라보라토리오스 델 드라. 에스테브.에스.에이. | 세로토닌-노르에피네프린 재흡수 억제제들(SNRIs) 및 시그마 리셉터 리간드들 조합 |
WO2016083739A1 (fr) | 2014-11-26 | 2016-06-02 | Rhodia Operations | Composition de lanthane et d'actinium-227 |
GB201600154D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Isotope preparation method |
GB201600153D0 (en) * | 2016-01-05 | 2016-02-17 | Bayer As | Isotope preparation method |
CZ2016821A3 (cs) * | 2016-12-22 | 2018-07-04 | České vysoké učení technické v Praze | Kombinace pro radionuklidovou terapii pro použití jako léčivo |
AR110995A1 (es) | 2017-02-24 | 2019-05-22 | Bayer Ag | Combinación de inhibidores de quinasa atr con sal de radio-223 |
AU2018265386B2 (en) | 2017-05-11 | 2020-07-23 | Alpha Tau Medical Ltd. | Polymer coatings for brachytherapy devices |
CN111918699B (zh) | 2018-04-02 | 2024-03-08 | 阿尔法陶医疗有限公司 | 放射性核素的受控释放的装置 |
EP3563875A1 (de) * | 2018-05-04 | 2019-11-06 | Ceské vysoké ucení technické v Praze | Radium für radionuklidtherapie, zusammen mit calciummetabolisme- beeinflüssender therapie |
FR3086186B1 (fr) * | 2018-09-26 | 2022-01-28 | Orano Med | Procede de production de plomb-212 a partir d'une solution aqueuse comprenant du thorium-228 et ses descendants |
FR3088769B1 (fr) * | 2018-11-15 | 2020-12-25 | Orano Med | Procede de preparation d'au moins un generateur a haute teneur en radium-228 |
US20220152228A1 (en) * | 2019-03-01 | 2022-05-19 | Washington University | Compositions and methods for radiotherapy using chelated radiotherapeutic agents and non-target tissue blockade |
RU2752845C1 (ru) * | 2020-05-13 | 2021-08-11 | Акционерное Общество "Наука И Инновации" | Способ получения высокочистого радия-223 |
CA3202211A1 (en) | 2020-12-16 | 2022-06-23 | Alpha Tau Medical Ltd. | Diffusing alpha-emitters radiation therapy with enhanced beta treatment |
CN113066598B (zh) * | 2021-03-25 | 2023-08-08 | 中国科学院近代物理研究所 | 一种从高能质子束辐照232Th靶引起的散裂反应中分离纯化223Ra的方法 |
US11964168B2 (en) | 2021-06-10 | 2024-04-23 | Alpha Tau Medical Ltd. | Diffusing alpha-emitter radiation therapy for prostate cancer |
WO2023159229A1 (en) | 2022-02-21 | 2023-08-24 | Bayer Healthcare Llc | System, method and device for delivery of a therapeutic or diagnostic agent |
WO2023159230A1 (en) | 2022-02-21 | 2023-08-24 | Bayer Healthcare Llc | System, method and device for delivery of a therapeutic or diagnostic agent |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH668489A5 (de) * | 1982-01-22 | 1988-12-30 | Vnii Mineralnogo Syrya | Radiometrisches verfahren zur bestimmung der konzentration natuerlicher radiumisotope und einrichtung zur durchfuehrung des verfahrens. |
AU626348B2 (en) * | 1988-10-14 | 1992-07-30 | Mallinckrodt, Inc. | Radiolabelled particulate composition |
US4970062A (en) * | 1989-05-30 | 1990-11-13 | The United States Of America As Represented By The United States Department Of Energy | Colloid labelled with radionuclide and method |
AU3177893A (en) * | 1991-11-14 | 1993-06-15 | Battelle Memorial Institute | Method for diagnosing and treating cancer |
CA2163107C (en) * | 1993-05-17 | 2001-04-17 | David Milton Goldenberg | Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
US5809394A (en) * | 1996-12-13 | 1998-09-15 | Battelle Memorial Institute | Methods of separating short half-life radionuclides from a mixture of radionuclides |
US6117413A (en) * | 1997-11-12 | 2000-09-12 | Battelle Memorial Institute | Radionuclide-binding compound, a radionuclide delivery system, a method of making a radium complexing compound, a method of extracting a radionuclide, and a method of delivering a radionuclide |
NO310544B1 (no) * | 1999-01-04 | 2001-07-23 | Algeta As | Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben |
NO314537B1 (no) * | 1999-12-06 | 2003-04-07 | Anticancer Therapeutic Inv Sa | Reseptorbindende konjugater |
NO312708B1 (no) * | 2000-02-21 | 2002-06-24 | Anticancer Therapeutic Inv Sa | Radioaktive liposomer til terapi |
NO313180B1 (no) * | 2000-07-04 | 2002-08-26 | Anticancer Therapeutic Inv Sa | Bensökende alfapartikkel emitterende radiofarmasöytika |
GB0213261D0 (en) * | 2002-06-10 | 2002-07-17 | Anticancer Therapeutic Inv Sa | Method |
US20060228297A1 (en) * | 2003-04-15 | 2006-10-12 | Roy Larsen | Thorium-227 for use in radiotherapy of soft tissue disease |
GB0308731D0 (en) * | 2003-04-15 | 2003-05-21 | Anticancer Therapeutic Inv Sa | Method of radiotherapy |
-
1999
- 1999-01-04 NO NO990001A patent/NO310544B1/no not_active IP Right Cessation
- 1999-12-17 AT AT99960058T patent/ATE331534T1/de active
- 1999-12-17 PT PT99960058T patent/PT1140212E/pt unknown
- 1999-12-17 EA EA200100642A patent/EA003496B1/ru not_active IP Right Cessation
- 1999-12-17 TR TR2002/01440T patent/TR200201440T2/xx unknown
- 1999-12-17 CN CN2004100749238A patent/CN1767078B/zh not_active Expired - Lifetime
- 1999-12-17 DK DK99960058T patent/DK1140212T3/da active
- 1999-12-17 WO PCT/NO1999/000392 patent/WO2000040275A2/en active Search and Examination
- 1999-12-17 IL IL14413599A patent/IL144135A0/xx not_active IP Right Cessation
- 1999-12-17 KR KR1020017008497A patent/KR100671387B1/ko active Protection Beyond IP Right Term
- 1999-12-17 TR TR2002/01442T patent/TR200201442T2/xx unknown
- 1999-12-17 NZ NZ513135A patent/NZ513135A/en not_active IP Right Cessation
- 1999-12-17 ES ES99960058T patent/ES2268888T3/es not_active Expired - Lifetime
- 1999-12-17 EP EP99960058A patent/EP1140212B1/de not_active Expired - Lifetime
- 1999-12-17 AU AU17004/00A patent/AU774991B2/en active Active
- 1999-12-17 CN CNB998161020A patent/CN1194764C/zh not_active Expired - Lifetime
- 1999-12-17 MX MXPA01006823A patent/MXPA01006823A/es active IP Right Grant
- 1999-12-17 DE DE69932183T patent/DE69932183T2/de not_active Expired - Lifetime
- 1999-12-17 BR BR9916768-9A patent/BR9916768A/pt not_active Application Discontinuation
- 1999-12-17 CA CA002358498A patent/CA2358498C/en not_active Expired - Lifetime
- 1999-12-17 TR TR2001/02707T patent/TR200102707T2/xx unknown
- 1999-12-17 JP JP2000592029A patent/JP4649044B2/ja not_active Expired - Lifetime
- 1999-12-17 NZ NZ534618A patent/NZ534618A/xx not_active IP Right Cessation
- 1999-12-17 NZ NZ545023A patent/NZ545023A/en not_active IP Right Cessation
-
2000
- 2000-01-03 US US09/476,569 patent/US6635234B1/en not_active Expired - Lifetime
-
2001
- 2001-07-02 ZA ZA200105431A patent/ZA200105431B/en unknown
-
2003
- 2003-06-12 US US10/459,941 patent/US20030206857A1/en not_active Abandoned
-
2006
- 2006-09-28 CY CY20061101404T patent/CY1105634T1/el unknown
- 2006-11-02 HK HK06112108.8A patent/HK1090750A1/xx not_active IP Right Cessation
-
2010
- 2010-04-20 JP JP2010096736A patent/JP5433490B2/ja not_active Expired - Lifetime
-
2014
- 2014-04-09 LU LU92425C patent/LU92425I2/fr unknown
- 2014-05-07 BE BE2014C028C patent/BE2014C028I2/fr unknown
- 2014-05-09 NO NO2014010C patent/NO2014010I1/no not_active IP Right Cessation
- 2014-05-13 CY CY2014020C patent/CY2014020I1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69932183D1 (de) | ANWENDUNG VON ZIELGERICHTETEM RADIUM 223 FüR PALLIATIVE UND THERAPEUTISCHE BEHANDLUNG VON KNOCHENKREBS | |
DE60236413D1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
MXPA03006771A (es) | Anticuerpos modificados y metodos de uso. | |
MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
CY1105818T1 (el) | Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου | |
ATE444086T1 (de) | Therapeutische zusammensetzungen und verfahren zur behandlung von periodontitis mit entzündunshemmenden mitteln | |
DE60028863D1 (de) | Elektrochirurgisches Handstück zur Behandlung von Gewebe | |
BR9813318A (pt) | Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário | |
DE69426530D1 (de) | Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz | |
MXPA00010254A (es) | Tratamiento de disfuncion sexual en ciertos grupos de pacientes. | |
ATE252896T1 (de) | Endokrintherapie für brustkrebs: kombinierte behandlung mit tamoxifen und alkyl-pcdfs | |
EP1139750A4 (de) | Auf knochen-sialoprotein basierte toxische gentherapie zur behandlung von kalzifizierten tumoren und geweben | |
DE69626691D1 (de) | Komponente b als wundheilendes mittel | |
UA42335A (uk) | Спосіб лікування гнійних ран | |
UA32153A (uk) | Спосіб формування трансплантату для зведення на промежину при черевно-анальних резекціях прямої кишки | |
UA32302A (uk) | Спосіб усунення післяопераційних деформацій м'яких тканин | |
UA32173A (uk) | Спосіб лікування недорозвиненої середньої зони лицевого скелету | |
UA33571A (uk) | Спосіб лікування травматичного перелому нижньої щелепи | |
DE60308127D1 (de) | Pharmazeutische Zusammentsetzung zur medizinischen Behandlung von gutartiger prostathyperplasie, dessen Vorbereitungsmethode und dessen therapeutische Verwendung | |
UA36490A (uk) | Спосіб лікування гнійно-септичних захворювань м'яких тканин |